Things to Come | GenomeWeb

Things to Come

The next few years may see a number of changes to medicine, but Francis Collins, the director of the US National Institutes of Health, is most excited about the prospect of people being able to have their genomes sequenced at a reasonable cost to inform and tailor their medical care, as he tells USA Today's Brian Gallagher.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Hoping for More

Billion More?

Put It in the Jar

Greener Pastures

All the Generations

In PLOS this week: effect of variants linked to body shape differs by age and sex, transcriptome differences in bats with and without white-nose syndrome, and more.

A researcher argues that big prizes like the Nobel or Lasker awards send the wrong message about research.

Maria Freire, the president of the Foundation for the National Institutes of Health, discusses recent genomics-fueled advances with The Open Mind's Alexander Heffner.

Three researchers win the Nobel Prize for their efforts to develop treatments for parasitic diseases.